Biotech Leadership: How Jean Liu Mastered The Shift From GC To Board Roles
Biotech leadership requires a unique blend of scientific acumen, legal expertise, and business savvy, a combination that ourΒ ...
President, Didi
Search every verified Jean Liu interview, podcast appearance, and on-the-record quote β each transcript cross-checked by AI and human review to confirm speaker identity. Jean Liu, president of Didi Chuxing, has spoken about her transition from general counsel to board roles in the biotechnology sector, describing how she secured board seats while still serving as a chief legal officer. She noted that she focuses on asking open-ended questions about business direction rather than acting strictly as a lawyer. Liu also reflected on her early law school experience, calling herself a "mediocre student" who had to learn how to write analytical answers with no single right answer. She described the biotech industry as being on "the knife edge of wild success and wild failure," and said that being a biotech GC taught her how to handle bad news by triaging priorities. Liu has also discussed her decision to leave Goldman Sachs as a managing director to join Didi in 2014 as chief operating officer, when the company was valued at around $500 million and had 700 employees. She said she had tried three times to invest in Didi on behalf of Goldman but failed due to the firm's strict due diligence process. Liu stated that after two fatal safety incidents on Didi's platform in 2018, the company launched more than 40 safety features including facial recognition and route sharing, and created an online forum to solicit public feedback on sensitive topics such as whether drivers should be allowed to reject drunk passengers. She noted that during the COVID-19 pandemic, Didi lost 80% of its business in two months but that the business later returned to its peak.
“A general counsel is largely a lawyer who specializes in the business that the client does.”
“In a biotech company you're always on the cusp of wild success or wild failure β you're literally on the knife edge of wild success and wild failure.”
“Most biotechs are not profitable β drugs are very prone to failure; getting a drug approved is a really big deal and everyone spends a tremendous amount of money trying to do it.”
“When the stock's really high you can actually raise a lot of money and you can do a lot of deals and so things go crazy β and just as quickly when something runs afoul, things can come down.”
“If you're an in-house lawyer you only have one client; the pro is deep specialization in the business, but the con is if the company doesn't do well your career can get stuck there.”
“Being a biotech GC teaches you how to handle bad news β you learn to calm yourself: get a grip, take a deep breath, and triage what the number one thing is that you have to do.”
“The role of the board is to set the strategic direction of the company, but it has to be informed by the facts on the ground that come from management.”
“Often the legal solution isn't the answer β you must first exquisitely understand what the client really needs and what the company wants to do before proposing legal approaches.”
“Tell people that you want to be a board member β networking, mentors, and industry programs (I took a board-ready cohort through Women Bio) helped me secure board seats while I was still chief legal officer.”
“People expect me to act like a lawyer on boards, but I rarely do; I focus on asking open-ended questions about where the business should go and only then address legal tactics.”
“My first year in law school, I would say I was a mediocre student and it took me a while to get used to it.”
“Writing blue books in our case β you answer questions where there's no real right answer and it's more looking at your analysis and understanding sort of the reasons behind why things are decided the way they are.”
“I actually think science is pretty good at that but the expression of it β the writing down of it β people make jokes about like science is not being terrific in that aspect.”
“Our training is to basically be able to be advocates, which is to express whatever our positions are in hopefully the best and the most eloquent way and the most understandable and most persuasive way.”
“That was something I actually had to learn a lot β I had to start from the beginning.”
Biotech leadership requires a unique blend of scientific acumen, legal expertise, and business savvy, a combination that ourΒ ...
Biotech leadership requires a unique blend of scientific acumen, legal expertise, and business savvy, a combination that ourΒ ...
Week no. of 21 of #52weeksofdesign is the undeniable force of nature, and maven of multi-tasking Jean Liu. Jean has undeniable smarts, with degrees from both Georgetown and Harvard, both in subjects unrelated to design. A however, after spending the better part of a decade working for her familyβs business, Litex, Jean pursued her passion for interior design and opened her own firm to great acclaim in 2007. Sitting at the helm of Jean Liu Design isnβt her only job, though. She is a wife, mother, Chairman of the Board for Litex, entrepreneur with her own outdoor furniture companies β Stori Modeβ¦
Jean Liu, President of Didi Chuxing shares her learnings on redefining tech company's connection to the community, supportingΒ ...
Didi Chuxing is now "even more confident and more committed" to the idea of entering global markets in the wake of theΒ ...
Nov.22 -- Jean Liu, president at Didi Chuxing, discusses how the company overtook Uber Technologies Inc. in China and the importance of understanding the market. She speaks at Bloombergβs New Economy Forum in Beijing.
Sign in to search the full transcript archive, filter by topic, and access every quote from Jean Liu.
The summary and quote tags on this profile are produced with AI assistance from verified, first-person interview transcripts, then checked by our team to confirm the speaker's identity and the accuracy of every quote. See how we verify →